HERperspective
Where women's health expertise meets real-world practice.
Categories
/
Tags
TAGS
- BirthControl
- BirthControlOptions
- Body Composition
- CardiacCare
- CardiovascularHealth
- Clinical Education
- Contraception
- Contraceptives
- FamilyHealthHistory
- FamilyHistory
- FamilyPlanning
- FamilyPlanning101
- GLP-1
- GeneticCounseling
- GeneticRisk
- GeneticTesting
- Genetics
- GynecologicalHealth
- HERmedicine
- HERtalks
- Health Equity
- HealthAwareness
- HealthEducation
- HealthFacts
- HealthHistory
- HealthLiteracy
- HealthMyths
- HealthScreenings
- Healthcare Disparities
- HealthcareBasics
- HealthcareChoice
- HealthcareChoices
- HealthcareGuide
- HealthcareQuestions
- HeartAttackSymptoms
- HeartDisease
- HeartHealth
- HeartHealthy
- Hormone Therapy
- HormoneBalance
- HormoneHealth
- HotFlashes
- LifeStages
- Medical Bias
- MedicalFacts
- MedicalMyths
- Menopausal Hormone Therapy
- Menopause
- MenopauseManagement
- MenopauseRelief
The Pink Elephant Part 1: MHT After Breast Cancer — A Review of the Data
Four million breast cancer survivors. Most can't get a clinician to have the MHT conversation — and the data isn't saying what most clinicians think it's saying.
The Pink Elephant, Part 2: Four Cases, Four Conversations That Don't Happen Often Enough
Four cases spanning the full risk spectrum — from high-risk and undiagnosed to a decade post-tamoxifen. A panel willing to disagree in real time about where the evidence ends and clinical judgment begins.
You’re Not Losing Your Mind. It Might Be Perimenopause.
Most women are never told what to expect from perimenopause — not the full symptom picture, not the treatment options, not the mental health piece. This HERtalks panel covers all of it.
Weight Gain at Midlife Isn't a Willpower Problem. Here's What's Actually Happening.
Most women have been told midlife weight gain is a willpower problem. The data says otherwise — and so does Dr. Angela Fitch, one of the country’s leading obesity medicine specialists.
Why Women’s Health Procedures Are Literally Worth Less Than Men’s—And Why It Matters
Did you know that a vaginal biopsy is worth less to the healthcare system than a penile biopsy? Research shows that male-specific procedures are reimbursed up to 30% more than equivalent female ones, leading to delayed surgeries and poorer health outcomes for women. This systemic undervaluation is rooted in outdated CMS billing codes — and it’s time to demand change.